AllianceBernstein’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $371K | Sell |
27,810
-700
| -2% | -$9.35K | ﹤0.01% | 2811 |
|
|
2025
Q1 | $291K | Sell |
28,510
-108,914
| -79% | -$1.11M | ﹤0.01% | 2785 |
|
|
2024
Q4 | $2.18M | Sell |
137,424
-20,781
| -13% | -$329K | ﹤0.01% | 1914 |
|
|
2024
Q3 | $9.19M | Buy |
158,205
+7,743
| +5% | +$450K | ﹤0.01% | 1227 |
|
|
2024
Q2 | $6.88M | Buy |
150,462
+58,604
| +64% | +$2.68M | ﹤0.01% | 1362 |
|
|
2024
Q1 | $6.08M | Buy |
91,858
+70,738
| +335% | +$4.68M | ﹤0.01% | 1391 |
|
|
2023
Q4 | $840K | Hold |
21,120
| – | – | ﹤0.01% | 2360 |
|
|
2023
Q3 | $673K | Hold |
21,120
| – | – | ﹤0.01% | 2419 |
|
|
2023
Q2 | $849K | Buy |
21,120
+4,820
| +30% | +$194K | ﹤0.01% | 2359 |
|
|
2023
Q1 | $696K | Hold |
16,300
| – | – | ﹤0.01% | 2401 |
|
|
2022
Q4 | $783K | Buy |
16,300
+1,400
| +9% | +$67.2K | ﹤0.01% | 2401 |
|
|
2022
Q3 | $561K | Sell |
14,900
-100
| -0.7% | -$3.77K | ﹤0.01% | 2589 |
|
|
2022
Q2 | $414K | Buy |
15,000
+2,800
| +23% | +$77.3K | ﹤0.01% | 2755 |
|
|
2022
Q1 | $663K | Hold |
12,200
| – | – | ﹤0.01% | 2555 |
|
|
2021
Q4 | $714K | Sell |
12,200
-2,900
| -19% | -$170K | ﹤0.01% | 2585 |
|
|
2021
Q3 | $597K | Hold |
15,100
| – | – | ﹤0.01% | 2683 |
|
|
2021
Q2 | $641K | Buy |
15,100
+1,500
| +11% | +$63.7K | ﹤0.01% | 2698 |
|
|
2021
Q1 | $837K | Sell |
13,600
-900
| -6% | -$55.4K | ﹤0.01% | 2464 |
|
|
2020
Q4 | $1.02M | Buy |
14,500
+7,500
| +107% | +$529K | ﹤0.01% | 2271 |
|
|
2020
Q3 | $270K | Buy |
7,000
+900
| +15% | +$34.7K | ﹤0.01% | 2851 |
|
|
2020
Q2 | $229K | Buy |
+6,100
| New | +$229K | ﹤0.01% | 2957 |
|